Looking to publish in Clinical and Translational Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginClinical and Translational Medicine is an open access journal focused on accelerating the translation of preclinical research to clinical application and communication between basic and clinical scientists. It emphasizes a bench-to-bedside approach and welcomes submissions from clinicians, researchers, policy makers, and industry across areas of clinical and translational medicine, with themed topics including clinical bioinformatics, clinical trans-omics, single-cell biomedicine, stem cell biology and therapy, clinical genomics, vaccines and immunotherapy, and chronic metabolic diseases.
Looking to publish in Clinical and Translational Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Clinical and Translational Medicine accepts the following article types. Click on an article type to view submission instructions.
Original Research Article
Review Article
Invited Letter
Short Communication
Letter To The Journal
Recent Publications
Pattools‑implemented methylation vector analysis reveals aberrant subtype‑specific methylation in lung cancer across tissue and plasma cfDNA
Zehua Dong, Yifeng Luo, Tingting Hu, Yihang Cheng, Qiaoling Ren, Li Xu, Yuan Tan, Wei Li, Yaoxiang Sun, Mingzhi Chen, Zhonghua Shen, Bin Zhang, Youhuang Bai, Yue Tao, Zhihong Cao, Deqiang Sun
PRAME promotes invasion and metastasis of salivary adenoid cystic carcinoma by regulating RARα stability via the cullin2 ubiquitin‐proteasome system
Xudong Wang, Tingyao Ma, Yixin Jing, Tianyi Li, Xi Zhao, Guohan Zhao, Ran Gao, Lu Kong, Xiaohong Chen
Overcoming the cytosine base editing barrier: Virus‐like particles with uracil‐DNA glycosylase inhibition unlocking the clinical potential
Yuqing Wu, Xingyu Zhu, Junjie Zhu, Jia Chen, Jiaxu Hong
NSUN4‐dependent m5C modification facilitates mitochondrial fission to accelerate diabetic nephropathy process via regulating SMURF1/CAMK1 axis
Danyi Yang, Yinyin Chen, Hao Li, Guoyong Liu, Yang Gao, Liyu He
Venetoclax for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: Prospects, resistance mechanisms and management strategies
Jinlin Zhang, Jile Liu, Mohan Zhao, Xiaoyu Zhang, Linlin Liu, Mengnan Li, Changze Cao, Rui Zhang, Mingfeng Zhao
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 7 days; submission to acceptance (median): 105 days; acceptance to publication (median): 15 days.
Reformat to Clinical and Translational Medicine using Livewrite PremiumIs a cover letter required?
A cover letter is required. It must explain why the manuscript should be published in Clinical and Translational Medicine, address any issues relating to journal policies, declare potential competing interests, confirm all authors approved the submission, confirm the work has not been published or submitted elsewhere, and name the special issue if applicable.
Reformat to Clinical and Translational Medicine using Livewrite PremiumWhat are the publication costs?
Open access article publication charge (APC) applies; institutional or funder payment may cover the APC.
Reformat to Clinical and Translational Medicine using Livewrite Premium